An early step in the formation of the extraembryonic and intraembryonic vasculature is endothelial cell differentiation and organization in blood islands and vascular structures. This involves the expression and function of specific adhesive molecules at cell-to-cell junctions. Previous work showed that endothelial cells express a cell-specific cadherin that is organized at cell-to-cell contacts in cultured cells and is able t o promote intercellular adhesion. In this study, we investigated whether VE-cadherin could be involved in early cardiovascular development in the mouse embryo. We first cloned and sequenced the mouse VE-cadherin cDNA. At the protein level, murine VE-cadherin presented 75% identity (90%, considering conservative amino acid substitutions) with the human homologue. Transfection of murine VEcadherin cDNA in L cells induced Ca+'-dependent cell-to-cell aggregation and reduced cell detachment from monolayers. In situ hybridization of adult tissues showed that the murine molecule is specifically expressed by endothelial cells. In mouse embryos, VE-cadherin transcripts were detected at the very earliest stages of vascular development (E7.5) in URING EMBRYONIC development, the first rudiments of the vascular system are mesenchymal cell aggregates in the yolk sac known as blood islands. Blood islands consist of immature hematopoietic precursor cells, found in the interior of the island, and endothelial cells at the periphery. The close association of endothelial cells and hematopoietic cells has led to the idea that in the yolk sac, endothelial cells and blood cells may have a common precursor, the hemangioblast. This hypothesis is supported by the fact that there are antibodies against immature blood cells that also react with endothelial cell^."^ After blood islands have formed, they fuse and give rise to a primary vascular plexus. Within the embryo, blood vessels are formed by vasculogenesis and angi~genesis.~" Vasculogenesis is a process during which angioblasts differentiate in situ to form a primary capillary plexus that is rapidly remodelled either by The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact.
mesodermal cells of the yolk sac mesenchyme. At E9.5, expression of VE-cadherin was restricted to the peripheral cell layer of blood islands that gives rise t o endothelial cells. Hematopoietic cells in the center of blood islands were not labeled. At later embryonic stages, VE-cadherin transcripts were detected in vascular structures of all organs examined, eg, in the ventricle of the heart, the inner cell lining of the atrium and the dorsal aorta, in intersomitic vessels, and in the capillaries of the developing brain. A comparison with flk-l expression during brain angiogenesis revealed that brain capillaries expressed relatively low amounts of VEcadherin. In the adult brain, the level of VE-cadherin transcript was further reduced. By immunohistochemistry, murine VE-cadherin protein was detected at cell-to-cell junctions of endothelial cells. Overall, these data demonstrate that VE-cadherin is an early, constitutive, and specific marker of endothelial cells. This distinguishes this molecule from other cadherins and suggests that its expression is associated with the early assembly of vascular structures. 0 1996 by The American Society of Hematology.
fusion, to give rise to larger vessels, or by regression and migration. In contrast, vascularization of some organs, such as brain and kidney, is dependent on angiogenesis."' In this case, the vasculature is formed by new vessels sprouting from preexisting vessels and invading the developing organ.
Both vasculogenesis and angiogenesis are regulated by the capacity of endothelial cells to adhere to each other and assemble into new vascular structures. Adhesive receptors for extracellular matrix and for cell-to-cell adhesion play a pivotal role in these Little information is available, however, on their expression and biologic role in endothelial cells during the embryonic development of the vasculature.
Among the different groups of adhesive receptors, a family of &"-dependent adhesive molecules, called cadherins, have been found to be particularly important in the morphogenesis of different organ^.'^"' These molecules, by promoting homotypic type of cell-to-cell interaction, are responsible for maintaining intercellular cohesion in tissues. Cadherins exhibit considerable sequence homology and are highly conserved during evolution. Their expression controls cell aggregation during the mesenchymal-epithelial transformation and cell segregation. Initially, three major cadherins (E-, N-, and P-cadherin) were characterized.
However, the number of the members of the cadherin family has increased dramatically during recent years. '" To determine in which tissues cadherins are functional, it is important to follow their distribution during embryogenesis. Overall, the spatiotemporal patterns of expression differ for each individual cadherin; however, in most cases, different cadherins may be expressed simultaneously within a tissue, and the same cadherin can be found in a variety of embryonic cell types and tissue^.'^"' Human endothelial cells have been found to express at least two cadherins to a significant degree: N-cadherin" and vascular endothelial (VE)-cadherin (7B4 or cadherin-5).22.2' N-cadherin is also found in other cell types such as those of For personal use only. on November 11, 2017. by guest www.bloodjournal.org From the nervous system and skeletal and cardiac muscles, while VE-cadherin is expressed only in endothelial cells.24 In contrast with VE-cadherin, N-cadherin is rarely found at cellto-cell contacts in the endothelium. Rather, it remains diffused on the cell surface in vitro" and in vivo (unpublished data, May 1995), suggesting that it does not play a major role in the organization of cell-to-cell junctions. In humans, VE-cadherin could be found in all types of endothelium, in large and small vessels, arteries, veins, and in the microvasculature of all tissues examined. In contrast with most endothelial markers, it is not found in blood cells or in hematopoietic precursor^.'^ To study VE-cadherin expression during the development of the vascular system in the mouse embryo, we first sought to identify the murine counterpart of human VE-cadherin. We report the isolation and sequencing of the full-length cDNA clone encoding murine VE-cadherin. In situ hybridization experiments show that VE-cadherin is expressed very early during endothelial cell differentiation from mesodermal precursors. In the mouse, this molecule retains endothelial-specific localization and is expressed in most types of endothelium studied. During embryonic development, VEcadherin appears to be partially downregulated in the brain vasculature, where endothelial cells organize specific junctional structures.
The high degree of conservation of VE-cadherin sequence between human and mouse and the widespread constitutive expression in essentially all types of endothelium suggest that VE-cadherin plays a fundamental biologic role in endothelial cells. As cells transfected with murine VE-cadherin cDNA acquire adhesive properties, it is conceivable that this molecule promotes endothelial cell recognition and cell-tocell adhesion, essential for the assembly and the integrity of vascular structures.
MATERIALS AND METHODS
Antibodies. Rabbit antisera were raised against peptides from mouse VE-cadherin and the mouse catenins a , P. and y. The following peptides were used: CSDPQEELII (C-terminus of VE-cadherin), CKKHVNPVQALSEFK (C-terminus of a-catenin), CMATQA-DLMELDMAMEPDRK (N-terminus of P-catenin), and CDG-DYPMDTYSDGLRPPYPTADH (C-terminus of y-catenin/plakoglobin).24 For immunization, peptides were crosslinked via their N-terminal cysteines to ovalbumin, using the bifunctional crosslinker 3-maleimidobenzoic acid N-hydroxysuccinimide ester (MBS). Rat monoclonal antibody (MoAb) to mouse PECAM-1 (MEC 13.3) has been previously characterized.26
Cells. 3T3 and L cells were from American Tissue Culture Collection (Rockville, MD). The murine erythromegakaryocytic cell line LIN 175" and the stromal cell line MS5'* were gifts from S. Fisher (INSERM U363, Hopital Cochin, Paris, France) and K.J. Mori (Niigata University, Niigata, Japan) respectively. Murine erythroleukemia (MEL) cells (Friend clone G9) were donated by Dr H. Eisen (Laboratoire d'Immunoparasitologie, Institut Pasteur, Paris, France). Mouse endothelioma cell lines (B-end, E-end, T-end, and H5V) were obtained and cultured as de~cribed.*~~*~ Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum (FCS). Sterile plastic ware was purchased from Falcon (Becton Dickinson, Lincoln Park, NJ); both culture medium and serum were purchased from Gibco (Life Technologies, Paisley, UK).
RNA extraction and Northern blot analysis. Total RNA was extracted and purified using the guanidium isothiocyanate/CsCI, method as previously de~cribed.~' Total RNA (10 pg per lane) was run in a standard formaldehyde/agarose gel, transferred onto nitrocellulose membrane (Schleicher and Schuell, Dassel, Germany), and fixed at 80°C under vacuum for 2 hours. Hybridization and washing conditions were as previously de~cribed.~' Library screening, DNA sequencing, and computer analysis. A XgtlO cDNA library from P4-P8 postnatal mouse brain capillaries3' was screened as previously described," using the cloned human VEcadherin coding region as probe." Plaques showing a strong positive hybridization signal were screened three times to obtain a single clone. Phage inserts were rescued in the pGEM3 vector and sequenced. The nucleotide and deduced protein sequences were screened against the EMBL and Swissprot DataBank using a FASTA program33 as implemented on the EMBnet computer resource. Detailed sequence analyses were performed with the PC/Gene Sequence Analysis Package (Intelligenetics Corp, Mountain View, CA).
Constructs and transfections. The mouse VE-cadherin cDNA containing pGEM3 plasmid was cut with EcoRI enzyme, and the insert was subcloned into the pECE expression vect09~ to yield the pECE-VE-cadherin construct.
L cells were plated at 3 X lo6 to 4 X lo6 cells per 100-mm petri dish in DMEM with 10% FCS. After 18 to 24 hours, they were transfected by calcium phosphate precipitation with 17 pg pECE-VE-cadherin and 3 pg pSV,neo plasm id^.^' Twenty-four hours later, cells were washed once with serum-free medium and cultured for a further 48 hours in DMEM with 10% FCS. They were then detached, plated at 1 X lo6 per 100-mm petri dish, and grown in the presence of 1 m g / d G-418 (Geneticin; Gibco). After about 10 days in selective medium, the surviving colonies were ring-cloned. G-41 8-resistant clones were screened for VE-cadherin expression by indirect immunofluorescence microscopy.
The VE-transfectants were expanded in the presence of G-418 (800 pglml) before freezing for stock storage. After thawing, the cells were cultured in the absence of G-418. VE-cadherin expression was stable for at least 20 in vitro passages (splitting ratio, 1:15 to 1:20). VE-transfectants were regularly checked for mycoplasma contamination. Control clones transfected with the pECE and pSV,neo plasmids without insert were selected and grown in the same way.
Western blot. Western blots of cell extracts were performed as previously de~cribed.~" Briefly, cells grown to tight confluency were washed twice with phosphate-buffered saline (PBS) and twice with serum-free DMEM. Cells were extracted with 1 % Nonidet P40,0.5% sodium dodecyl sulfate (SDS) in TBS (10 mmol/L Tris HC1, 150 mmoVL NaCl, pH 7.51, 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), and 20 U/mL aprotinin for 20 minutes on ice. Cell extracts were passed through a 21-gauge needle to shear DNA and centrifuged at 13,000 rpm for 5 minutes at 4°C. The supernatants corresponding to 3 X lo5 cells were separated by SDS-electrophoresis on a 7.5% SDS-polyacrylamide gel. The gel was then incubated for 30 minutes (2 X 15 minutes) in transfer buffer (50 mmol/L Tris HCl, 95 mmoUL glycine, 1 mmol/L CaC1,). Proteins were electrotransferred onto nitrocellulose (Bio-Rad Laboratories, Richmond, CA) that was blocked with 10% low fat milk (Magist; Gespal, Milan, Italy) in PBS (blocking buffer) and incubated overnight with mouse VE-cadherin antibody. This was incubated for 1 hour with rabbit antimouse IgG (20 pg/mL; Dako, Glostrup, Denmark) followed by 90-minute incubation with 'ZSIodine-labeled protein A (about los cpm/mL; Amersham International, Buckingham, UK). Between the various steps, the nitrocellulose was washed several times with blocking buffer containing 0.1% Tween 20. The immunoreactive bands were detected by autoradiography.
Immunoprecipitation. Immunoprecipitations were performed on cell lysates of "S-methionine-labeled B-end cells as described prev i o~s l y .~~ For immunoprecipitation, 20 pL of the rabbit anti-VEFor personal use only. on November 11, 2017. by guest www.bloodjournal.org From cadherin antiserum or the corresponding nonimmune serum or 20 pg of affinity-purified anti-catenin rabbit IgG were used.
Immunofluorescence staining. L cells were cultured on glass coverslips (13 mm diameter) set in a 24-well plate. Cells were fixed with 3% paraformaldehyde, permeabilized with 0.5% TX-100, and processed for indirect immunofluorescence micro~copy.~~ Incubation with the primary antibody was followed by rhodamine-conjugated secondary antibody (Dakopatts, Glostrup, Denmark) in the presence of fluorescein-labeled phalloidin (Sigma Chemical CO, St Louis, MO), with several rinsings in 0.1% bovine serum albumin (BSA)-TBS between the various steps. Coverslips were then mounted in Mowiol 4-88 (Calbiochem, La Jolla, CA). For analysis of VE-cadherin expression in tissue sections, acetone-fixed, air-dried cryostat sections (8 mm) were prepared from snap-frozen tissue specimens and stained using an immunofluorescence technique. Sections were incubated (30 minutes each, with PBS washes in between) with primary antibodies followed by rhodamine-conjugated secondary antibodies (Jackson Laboratories, West Grove, PA). These were examined using a Zeiss Axiophot (Carl Zeiss, Oberkochen, Germany) microscope and photographed using Kodak TMax P3200 films (Eastman-Kodak, Rochester, NY).
Cell aggregation. In preliminary experiments, it was determined that washing the cells several times with Gaff and Mg++ PBS followed by incubation in Ca++ and Mg++ PBS for 15 minutes at 37°C maximally preserved VE-cadherin antigen on the cell surface while maintaining virtually 100% cell viability. Then 0.01% trypsin (from bovine pancreas, type 111; Sigma) in Hank's balanced salt solution with 25 mmoVL Hepes (HHBSS), 10 mmol/L CaCI,, and 5 mmoVL MgCI2 was added and maintained on the cells for the shortest time interval before the appearance of intercellular retraction (usually 5 to 7 minutes, with the progression of trypsin effect carefully monitored under microscope). Adherent cells were completely and rapidly dislodged by sharply striking the flasks. Trypsin was neutralized by adding DMEM with 10% FCS and 0.1% soybean trypsin inhibitor (SBTI; Sigma). The cells were centrifuged and resuspended in HHBSS without Ca++ and Mg++ and then centrifuged and resuspended in 1% BSA in HHBSS Ca++ and Mg++-free at a concentration of 4 X 10s/mL. Cell suspensions (0.5 mL per well) were seeded in a 24-well plate previously coated with 1% BSA to prevent cell adhe~ion,3".'~ and 2 mmoVL CaCI2 was added to start calcium-dependent aggregation. Controls without calcium were always run in parallel. Incubation was for 90 minutes at 37°C on a rotating platform (80 rpm). The reaction was stopped with 5% glutaraldehyde (electron microscopy grade, Sigma; 0.5 mL per well). The initial number of particles (NtO) and the number of particles at 90 minutes (Nt90) were counted using a ZM Coulter Counter (Coulter Counter Electronics Ltd. Luton, UK; window set, 6 to 100 pm). Aggregation was quantitated by applying the formula (NtO -Nt9O)/NtO x 100, as described previo~sly.~'
To determine whether the aggregates were homogeneous or heterogeneous, either control or VE-cadherin transfectants in suspension were labeled with 2 pmol/L BCECF-AM [2',5'-bis(2-carboxyethyl)-5(and-6) carboxyfluorescein acetoxymethylester; Molecular Probes, Eugene, OR] as previously described." Labeled cells (0.25 mL) were mixed with 0.25 mL unlabeled cells in a well of a 24-well plate. Aggregation was induced as described above by the addition of 2 mmol/L CaCl, . Aggregates were observed by both phase contrast and fluorescence microscopy as previously described.)' Cell migration. Cells were cultured for 5 days in 24-well plates to obtain a confluent cell layer. The culture medium was aspirated, and areas of confluent cells were removed using a plastic tip. In all the slides, we removed, at a regular distance, eight areas of cells corresponding to the slide diameter. The remaining cells were washed twice with culture medium to remove cell debris and were incubated at 37°C in culture medium. At the time intervals indicated, the cells were fixed with Fast Green (0.02% in methanol) and stained with crystal violet (0.5% in methanol-water 20:80). The leading edge of the migrating cells was easily distinguishable by its relatively lighter staining in comparison with the heavy staining of the cell layer at the original edge." The distance of migration was measured using a micrograduated scale (Nikon, Tokyo, Japan) adapted to the optics of a Nikon inverted phase contrast microscope (100 X magnification). Twelve observations, obtained in three adjacent wells, were recorded for each cell type at each time interval.
In situ hybridization. The techniques used for in situ hybridization were essentially as de~cribed.~' Frozen sections (IO pm) of organs of mouse embryos (Balb/c) were prepared and used for hybridization. Single-stranded, "S-labeled antisense or sense RNA probes were generated by in vitro transcription using T3 or 'I7 RNA polymerases as described by the manufacturer (Stratagene, La Jolla, CA).
The VE-cadherin probe used for in situ hybridization was generated from a Sph I-EcoRI fragment of the murine cDNA corresponding to nucleotides 1 to 1740 (clone 4B) that contained less well-conserved sequences. The mouse flk-l probe encoded the extracellular domain and the transmembrane region.39 Sense RNA probes were used as a control and did not show specific hybridization. After hybridization, slides were coated with photographic emulsion (Kodak NTB-2). exposed for 2 weeks, developed, and stained with toluidine blue (0.02%).
RESULTS

Isolation and characterization of murine VE-cadherin cDNA.
A cDNA library of day P4-P8 mouse brain capillaries was screened with a human VE-cadherin probe. One clone of 2,529 bp was isolated and sequenced. The sequence showed an open reading frame of 2,348 bp, a 5' untranslated sequence of 43 bp, and a 3' untranslated sequence of 139 bp. The cDNA clone encodes a protein of 783 amino acids with a signal peptide sequence (SIG) as determined by computer analysis using the hydrophiliclhydrophobic algorithm,40 but lacks most of the precursor region (PRE) present in other cadherins (Fig 1) . In contrast with the human homologue, the murine VE-cadherin has only one ATG, which conforms to the Kozak consensus sequences for initiation of translation. Murine VE-cadherin presents the same five internal homologous repeats (EC1 to EC5), the transmembrane (TM) domain, and the cytoplasmic domain (CP) as most of the previously described cadherins (Fig 1) . Other motifs are also maintained: (1) the precursor protein cleavage site (KRDW) at amino acid position 44 to 47; (2) four cysteine residues at positions 486, 575, 577, and 586, which are conserved in all cadherins; (3) three putative calcium-binding motifs (DxNDNxP) at positions 140 to 146, 247 to 253, and 469 to 475, and (4) three repeats of four amino acids (LDRE) of unknown biologic function but conserved in all cadherins at positions 105 to 108,212 to 215, and431 to 434. These conserved motifs are marked in Fig 1. Comparison of the murine and human VE-cadherin deduced amino acid sequence revealed significant homology at both the nucleotide and protein level (Fig 1) . The overall level of nucleotide identity of the coding region with human VE-cadherin is 78%. The overall amino acid identity with human VE-cadherin is 75% (90% homology considering conservative substitutions). The amino acid sequence of VE-cadherin displays a moderate homology (21.3% identity and 19% conservation) with three other cloned mouse cadherins (E, P, and N cadherin; data not shown). Interestingly, the murine ,,* t * *t*.~*tll*t*.*l,,*,t,t,.***~,* ,*.*.*.* *_**l* **.*,* _**l***. *.*, ,* *.* f *)(I, .*****,* VE-cadherin protein presents a different pattern of glycosylation, with six potential sites in the mouse versus seven in humans.
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Expression of murine VE-cadherin in dtfferent organs and cell lines.
Different endothelial and nonendothelial cell lines as well as adult organs were analyzed by Northern blot hybridization experiments. As a hybridization probe, a part of the cDNA that encodes the less conserved regions of the protein, corresponding to the first 1,740 nucleotides, was used to avoid spurious results.
As shown in Fig 2, the VE-cadherin probe hybridized with a single mRNA band of about 4.1 kb. VE-cadherin mFWA was detected in four endothelial cell lines of different origin but not in 3T3 cells, two hematopoietic cell lines (MEL, LIN 175), or a bone marrow stromal cell line (MS5). Highly vascularized organs such as the lung and heart showed a marked expression of VE-cadherin mRNA. The kidney showed a lower amount of VE-cadherin mRNA, and it was barely detectable in brain and thymus.
Expression of VE-cadherin and analysis of its adhesive properties. To gain information on VE-cadherin biologic activity, L cells were transfected with a pECE-VE-cadherin cDNA. Successful transfection and selection were validated by Northern blot, Western blot, and immunoprecipitation analysis of VE-cadherin transfectants (Fig 3 N a and Ah). As shown in Fig 3Na, a band of approximately 4 .1-kb size was evident in H5V (lane 3), whereas a band of 2.5 kb was apparent in VE-cadherin transfectants (lane 2), but this was absent in control cells (lane 1, L cells transfected with the neomycin resistance gene only). The size of mRNA observed was consistent with the cDNA introduced (2,521 nucleotides long). As shown in Fig 3A/ b, Western blot analysis dernonstrated a specific band of 125-kD molecular weight (arrow) typical of VE-cadherin positive clones that was absent in control transfectants (lanes 2 and 1, respectively) . By immunoprecipitation analysis (Fig 3A/c) 3) .
When adherent L-cell monolayers were observed, VEcadherin stable transfectants were all positive by immunofluorescence staining with anti-VE-cadherin antibody (data not shown), and cell-to-cell junctions were decorated selectively, as previously reported for VE-cadherin distribution in human endotheli~m.'~ To evaluate if transfected mouse VE-cadherin was cornpetent in mediating adhesive interactions, transfectants were examined for their ability to aggregate from a single-cell suspension. As shown, transfected cells formed small aggregates in the presence of calcium, while control cells remained mostly dispersed (Fig 3B) . To determine whether aggregation would be confined to VE-cadherin cells in mixed suspension, aggregation assays were performed after mixing control and VE-cadherin transfectants. To distinguish between the two cell types, control cells were vitally labeled with the fluorescent dye BCECF (see Materials and Methods). Aggregates were examined by phase contrast and electron microscopy. It was noted that aggregation was essentially confined to the VE-cadherin-expressing cells, which were aggregated, while the control cells remained mainly dispersed (data not shown). Overall, these results were consistent with those obtained using human VE-cadherin tran~fectants.~'
As a further indication of the strength of intercellular contacts in VE-cadherin transfectants, we analyzed the capacity of the cells to detach from the neighboring cells and migrate into a denuded area produced in the cultured confluent monolayer.3os4' Standard areas of cell detachment and removal were produced as described in Materials and Methods. At different times after this, the distance covered by the migrating front was measured. As shown in Fig 3C, after 8 hours, VE-cadherin transfectants had a lower migration rate and had covered a significantly shorter distance than controls. The observed changes in cell migration were not due to differences in the proliferative rates of the various clones, because within the time course of the experiment, the number of VE-cadherin transfectants was not significantly different from control cells (data not shown).
Expression of VE-cadherin during mouse embryogenesis. To obtain more detailed information about the expression of VE-cadherin in the developing vascular system, in situ hybridization of frozen sections of mouse embryos at various stages of mouse development was performed. In the mouse, the first blood islands form approximately at embryonic (E) day 7.5. As shown in Fig 4, VE-cadherin mRNA was detected in mesodermal cells of the yolk sac mesenchyme at day E7.5 (Fig 4b and c) . Cells from the visceral endoderm and from embryonic ectoderm were negative. VE-cadherinexpressing cells were also detected in trophoblast cells and in blood vessels of the maternal decidua (Fig 4a and d) . In serial sections, comparison with flk-l receptor, which is an early marker for endothelial cell precursor^,^^.^^ showed that the expression domain of VE-cadherin in the yolk sac mesenchyme was more restricted than for flk-l (Fig 4b, c, e , and f), possibly reflecting an earlier onset of flk-l expression.
At day E9.5, VE-cadherin transcripts were detected in the mesodermal layer of the yolk sac (Fig 5a through d) . In blood islands, the expression was restricted to the peripheral cell layer, which gives rise to endothelial cells. In contrast, hematopoietic cells in the center of the blood islands were not labeled (Fig 5c and d) . VE-cadherin, thus, appears to be a very early marker of endothelial cell differentiation in the mouse. VE-cadherin transcripts were also detected in the developing placenta, with the highest levels of transcripts being in the outer spongiotrophoblast layer (Fig 5a and b) . In the embryo proper, developing vascular structures such as the dorsal aorta and the perineural vascular plexus expressed VE-cadherin (Fig 5a, b, e, and f) . This capillary plexus gives rise to the vasculature of the brain and the spinal cord. In the mouse, the onset of brain angiogenesis is approximately at day El I .'
In day-E I 1.5 mouse embryos, VE-cadherin transcripts were detected in the vascular structures of all developing organs examined. Specific transcripts were detected in the ventricle of the heart and decorated the inner cell lining of the atrium (Fig 6a) . Thin lines of transcripts were observed in the area of intersomitic vessels (Fig 6c) . VE-cadherin For personal use only. on November 11, 2017. by guest www.bloodjournal.org From For personal use only. on November 11, 2017. by guest www.bloodjournal.org From mRNA was also detected in the periphery of the developing brain and inside the neuroectoderm. This suggests that capillaries of the perineural vascular plexus and vascular sprouts, which have invaded the neural tissue, express VE-cadherin (Fig 6d) . The inner cell layer of the dorsal aorta was also positive (Fig 6b) .
Examination of day-E17.5 mouse embryos revealed continuous expression of VE-cadherin in the vascular structures of all organs examined, including the heart, vertebral vessels, capillaries of the thymus, and the dorsal aorta (Fig 6e) . The distribution of VE-cadherin mRNA was consistent with its localization in endothelial cells. In the brain, VE-cadherin transcripts were detected in the meningeal capillary plexus, in the brain itself, and inside the choroid plexus (Fig 6g,  i, and k) , suggesting that brain capillaries expressed VEcadherin. In comparison with the endothelial-specific receptor tyrosine kinase flk-l (Fig 6h) , capillaries inside the brain expressed relatively low amounts of VE-cadherin. This observation is interesting, as the blood-brain barrier is being formed in mid-to late-gestation embryos." In the adult brain, a low level of VE-cadherin expression was observed (data not shown). A low level of constitutive expression was also detected in the choroid plexus endothelium (data not shown).
VE-cadherin protein expression was then analyzed in the embryo and in the adult brain. A polyclonal antibody was raised against a peptide covering the nine C-terminal amino acids of the VE-cadherin sequence. This sequence was selected because it has no homology with other cloned cadherins. 23 The specificity of the antibody was further controlled by positive immunofluorescence staining, Western blot, and immunoprecipitation analysis of VE-cadherin transfectants (see Fig 3) and by negative immunofluorescence staining of cells expressing N-, P-, and E-cadherins (data not shown). The pattern of expression in mouse embryos, as detected by immunofluorescence staining in situ, correlated with the localization of VE-cadherin mRNA. Developing vascular structures such as the heart or brain capillaries expressed VE-cadherin protein (Fig 7a, c, and e) . The specificity for endothelium was confirmed by staining sections with a monoclonal antibody to another endothelial marker, PECAM-lKD3 1, in ~a r a l l e l . '~~~ Interestingly, not all the capillaries positive for PECAM-1 were also clearly positive for VE-cadherin, eg, intersomitic vessels (Fig 7c and d) . At this stage, there is no clear explanation for this observation. It is possible that, as the intensity of fluorescent staining obtained with the VE-cadherin antibody was less than that obtained in the case of the PECA"1 antibody, this is simply a function of the sensitivity of the procedure. In brain capillaries, intense staining by the anti-VE-cadherin antibody was localized at the cell boundaries (Fig 7f) , consistent with localization of the adhesion molecule at the cell-to-cell junctions.
DISCUSSION
We report here the molecular cloning, biologic characterization, and developmental expression of the murine VEcadherin, a constitutive, endothelial cell-specific cadherin. Cloning of murine VE-cadherin cDNA showed that this molecule is highly conserved across species. The sequence identity between human and murine VE-cadherin is 75% at the protein level (!IO% if conservative amino acid substitutions are considered). This suggests that the tertiary structure of murine VE-cadherin and its potential function(s) are likely to be very similar.
Murine VE-cadherin also presents a molecular organization similar to that of the human homologue. In human VEcadherin, VIV has been substituted for the HAV sequence, which is present in most cadherins previously described. In the mouse, this is LIV. In classical cadherins, the conserved HAV motif seems to be implicated in cadherin homophilic However, the HAV motif is not required for the biologic activity of all cadherins, as T-cadherin, which lacks this sequence, retains adhesive proper tie^?^ Previous studies on human VE-cadherinN and the studies reported here on murine VE-cadherin-transfected cells confirm that this also appears to be the case for VE-cadherin of these species.
L cells transfected with murine VE-cadherin were adherent to each other in a Ca++-dependent manner in the classical test of single-cell aggregation, as previously described for other cadherins. '5.20 This property was confined essentially to VE-cadherin-expressing cells, as only they were found in the aggregates. In general, the aggregates formed were relatively small (5 to 10 cells) when compared with the results obtained using cells transfected with other cadherins.37 This difference may be due to the particular sensitivity of the molecule to cleavage during cell deta~hment.'~ To obtain further information on the adhesive properties of VEcadherin in transfected cells, the capacity of these cells to dissociate from a monolayer and migrate into a denuded area was evaluated. Transfection of VE-cadherin significantly inhibited cell detachment and migration, suggesting that the expression of this molecule could indeed increase cohesion of cell-to-cell junctions.
To evaluate VE-cadherin expression in vivo in the mouse, Northern blot and in situ hybridization experiments were performed. Northern blot analysis of different organs and cell lines showed that VE-cadherin mRNA was present at high levels in endothelial cell lines and in highly vascularized organs, consistent with its localization in the endothelium. This was then demonstrated directly by in situ hybridization and immunofluorescence staining of different organs in the embryo.
These data indicate that murine VE-cadherin is a constitutive endothelial-specific marker. This property distinguishes this molecule from the majority of other cadherins. Indeed, with the exception of "cadherin, which is specifically found in skeletal muscle cells,* most of the other cadherins described are quite widespread and are simultaneously expressed in different cell types during de~elopment.'~**~ Other previously described endothelial markers have different features from VE-cadherin. Some of them such as QH-1 ,' PECAM-1 : 7 von Willebrand CD34," and P-selectin" are not strictly endothelial-specific but may be found in blood cells or hematopoietic precursors. Other markers depend on the functional state of the cells; ie, Eselectin is induced only after cell activation with inflammatory cytokines. H, heart; HS, septum of the heart; IV, intersegmental vessels; L, lung; NE, neuroectoderm; R, rib; S, somite; T, thymus; V, ventricle; VP, perineural vascular plexus.
tous but can be found only in the microvasculature of some organs. Overall, this suggests that VE-cadherin synthesis is subjected to strictly tissue-specific transcriptional mechanisms. Furthermore, the observation that VE-cadherin is constitutively expressed by the endothelium of most organs and tissues suggests that its biologic properties are required for the correct developmental organization of blood vessels. The very high degree of conservation of this molecule between mouse and humans and its very early expression during embryonic development are consistent with this notion.
VE-cadherin was detected in day-E7.5 embryos in mesodermal cell aggregates of the yolk sac mesenchyme. At later stages, in day-E9.5 embryos, it was found in the peripheral layer of the yolk sac blood islands. These structures are mesodermal derivatives that give rise to endothelial and hematopoietic lineages. The appearance of a peripheral cell layer distinct from a central cell cluster, is the first sign of separation of the hematopoietic and endothelial cell precursors. VE-cadherin is not expressed in hematopoietic cells but was found only in the peripheral endothelial cell precursors, suggesting that it could be involved in angioblast differentiation. It could be speculated that VE-cadherin synthesis reflects the segregation of endothelial cells and hematopoietic cells at a molecular level before this process is morphologically evident. Cadherin expression is typical of solid t i s s~e s . '~.~~ It is tempting to speculate that when angioblasts acquire the capacity to synthesize cadherins, they are able to aggregate and assemble into vascular structures. In contrast, hematopoietic and blood cells proliferate and circulate as single cells and, therefore, need to suppress cell-to-cell adhesion mechanisms. 
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The kinetics of VE-cadherin expression resemble those recently described for the adhesive molecule PECAM-1.-Similarly, the endothelial-specific members of the receptor tyrosine kinase family (flk-1, tek, and tie-2; quek-l and quekvelopment. This suggests that the endothelial developmental program is very early and that cells acquire cell-specific characteristics in a coordinated way. Interestingly, in day-E7.5 embryo, VE-cadherin expression in the yolk sac mesenchyme was more restricted than that of flk-l, suggesting that the onset of VE-cadherin expression may be later than that of flk-1. An attractive hypothesis is that VE-cadherin synthesis might be a consequence of growth factor receptor occupancy.
The origin and differentiation of endothelial cells in the proper embryo is still uncertain. Apparently, endogenous endothelial cell precursors are present in most mesodermal tissue^.'^ Some intraembryonic biood vessels, such as the dorsal aorta, are derived from the assembly of in situ differentiating endothelial cells (vasculogenesis).6 In contrast, other organs, such as the brain and kidney, are vascularized through the sprouting of new capillaries from preexisting vessels (angi~genesis).~' These studies demonstrated that VE-cadherin was expressed in the cells of the dorsal aorta and in the primordia of the endocardium. This expression profile could be indicative of the presence of intraembryonic endothelial cell precursors before and at the time of differentiation. The availability of a set of molecular probes, such as VE-cadherin, for detecting early stages of angioblast differentiation could help in defining the early steps of vascular development.
VE-cadherin is most probably present in endothelial cells forming the sprouting capillaries during angiogenesis in the brain. Its expression, however, is downregulated when capillary sprouts invade the brain in the later phases of development of the brain vasculature. A comparison of flk-l and VE-cadherin staining of endothelial cells in the brain showed that many vessels were flk-l -positive but VE-cadherinnegative. Endothelial cells of the brain vasculature have different features in respect to the endothelium of other types of vessels, and, in particular, they are able to tightly regulate vascular permeability, forming the so-called hematoencephalic barrier.58 Junctional organization in these cells presents, at the ultrastructural level, a high degree of specialization, and it is possible that specific molecular components, different from those present in other types of endothelium, may be involved in these
In conclusion, VE-cadherin is an early marker of endothelial cell differentiation in vivo. Given its adhesive properties and its localization at cell-to-cell junctions, it is liely that it participates in endothelial cell-to-cell-specific recognition during the assembly of developing vascular structures. Its persistence in the adult vasculature suggests that it also plays a primary role in maintaining the integrity of established vessels. For personal use only. on November 11, 2017. by guest www.bloodjournal.org From
